RH
RHC.AU Ramsay Health Care Ltd
- Market cap
- AUD 12.8B
- P/E
- 40.9x
- P/B
- 2.59x
- ROE
- 6.6%
- Dividend yield
- 1.60%
- Fundamental score
- 1.6/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is RHC.AU undervalued?
Graham numberRHC.AU trades 116.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ramsay Health Care Ltd fundamental analysis
8 of 22 checks passedROE 0/2
Low return on equity (6.6%), below 10%.
ROA 1/1
Return on assets (1.6%) is above the industry median (-0.3%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (1,266.9%) is above the 5-year average (-6.2% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (1,266.9%) is above the industry median (-1.5%).
Revenue Growth 1/2
Revenue grew 7.5% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (221.9%), above 100%.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is 1.7x against interest expense, below 5x.
PE vs Market 0/1
PE (40.9x) is above the market median (15.0x).
PE vs Industry 0/1
PE (40.9x) is above the industry median (27.1x).
PBV 0/1
Price to book (2.6x) is above the industry median (2.0x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 105.9, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield (1.6%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 62.5%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Ramsay Health Care Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ramsay Health Care Ltd
Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers …
Full company profileRamsay Health Care Ltd financial statements
Ramsay Health Care Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 8.67B | 9.14B | 11.5B | 11.9B | 12.9B | 13.1B | 15.0B | 16.7B | 17.8B | 18.6B |
| Gross Profit | 6.67B | 7.00B | 8.92B | 9.21B | 1.59B | 9.97B | 1.27B | 1.61B | 2.12B | 1.77B |
| Operating Income | 831M | 691M | 1.05B | 689M | 274M | 323M | 660M | 937M | 2.12B | 1.01B |
| EBITDA | 1.24B | 1.10B | 1.50B | 1.54B | 1.80B | 1.61B | 1.78B | 1.81B | 2.16B | 2.20B |
| Net Income | 489M | 376M | 545M | 284M | 449M | 274M | 298M | 889M | 24.0M | 329M |
| EPS | 2.38 | 1.86 | 2.65 | 1.36 | 1.97 | 1.20 | 1.31 | 3.88 | 0.10 | 1.43 |
| Balance Sheet | ||||||||||
| Total Assets | 8.34B | 9.31B | 12.5B | 18.1B | 19.3B | 19.5B | 21.0B | 20.9B | 22.5B | 21.2B |
| Total Liabilities | 5.98B | 6.87B | 9.51B | 13.8B | 14.8B | 14.9B | 16.2B | 15.4B | 16.8B | 15.6B |
| Shareholders' Equity | 2.28B | 2.36B | 2.54B | 3.75B | 4.03B | 3.93B | 4.15B | 4.90B | 5.02B | 4.96B |
| Cash & Short-term Investments | 420M | 771M | 745M | 1.50B | 1.00B | 314M | 656M | 662M | 786M | 730M |
| Total Debt | 3.35B | 3.95B | 5.59B | 9.52B | 10.6B | 10.7B | 11.9B | 10.9B | 12.2B | 11.0B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 882M | 995M | 903M | 1.68B | 1.48B | 716M | 1.28B | 1.29B | 1.48B | 1.44B |
| Capital Expenditure | 430M | 474M | 594M | 681M | 629M | 709M | 721M | 754M | 777M | 734M |
| Free Cash Flow | 452M | 521M | 310M | 1.00B | 852M | 7.00M | 559M | 539M | 704M | 708M |
| Ratios | ||||||||||
| ROE | 21.5% | 16.0% | 21.4% | 7.6% | 11.1% | 7.0% | 7.2% | 18.1% | 0.5% | 6.6% |
| ROA | 5.9% | 4.0% | 4.4% | 1.6% | 2.3% | 1.4% | 1.4% | 4.3% | 0.1% | 1.6% |
| Net Profit Margin | 5.6% | 4.1% | 4.7% | 2.4% | 3.5% | 2.1% | 2.0% | 5.3% | 0.1% | 1.8% |
| Debt to Equity | 1.47x | 1.68x | 2.20x | 2.54x | 2.62x | 2.72x | 2.86x | 2.23x | 2.42x | 2.22x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ramsay Health Care Ltd dividends
- Dividend yield
- 1.60%
- Forward dividend
- 0.97 AUD
- Payout ratio
- 62.5%
- Ex-dividend date
- Sep 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 206M | 0.89 | 62.5% |
| 2025 | AUD 162M | 0.70 | 673.3% |
| 2024 | AUD 158M | 0.69 | 17.8% |
| 2023 | AUD 237M | 1.04 | 79.4% |
| 2022 | AUD 371M | 1.63 | 135.4% |
| 2021 | AUD 125M | 0.55 | 27.9% |
| 2020 | AUD 335M | 1.60 | 118.0% |
| 2019 | AUD 321M | 1.56 | 58.9% |
| 2018 | AUD 306M | 1.51 | 81.3% |
| 2017 | AUD 272M | 1.33 | 55.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ramsay Health Care Ltd
- Insiders 18.01%
- Institutions 57.20%
- Public & others 24.79%
- Shares outstanding 231M
- Free float 186M
Top funds holding RHC.AU
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 2.62M | 1.15% | - | Oct 2020 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 1.12M | 0.49% | - | Dec 2020 |
| iShares Core MSCI EAFE ETF | 828K | 0.36% | - | Feb 2021 |
| iShares MSCI Eafe ETF | 606K | 0.26% | - | Feb 2021 |
| MFS International New Discovery Fund | 357K | 0.16% | - | Dec 2020 |
| Fidelity International Index Fund | 357K | 0.16% | - | Feb 2021 |
| JP Morgan ETF Tr-BetaBuilders Developed Asia ex-Japan ETF | 344K | 0.15% | - | Feb 2021 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 307K | 0.13% | - | Oct 2020 |
| FlexShares Tr-FlexShares STOXX Global Broad Infrastructure Index | 248K | 0.11% | - | Feb 2021 |
| iShares MSCI Eafe Growth ETF | 242K | 0.11% | - | Feb 2021 |
Ramsay Health Care Ltd company profile
- Company name
- Ramsay Health Care Ltd
- Ticker
- RHC.AU
- ISIN
- AU000000RHC8
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 91,400
- Fiscal year end
- June
- Address
- Level 7, Tower B, St Leonards, NSW, Australia, 2065
- Phone
- 61 2 9433 3444
- Website
- ramsayhealth.com
About Ramsay Health Care Ltd
Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.
Ramsay Health Care Ltd management
10- Ms. Natalie DavisMD, Group CEO & Director
- Dr. Brindan SureshGroup Executive Health and Strategy
- Mr. Stuart WintersChief Operating Officer - Australia
- Dr. John Doulis M.D.Group Executive Technology & Digital
- Ms. Kelly HibbinsGroup Head of Investor Relations
- Ms. Henrietta Rowe BECON, L.L.B., M.A.I.C.D.Group General Counsel, Group Executive Legal & Company Secretariat · born 1983
- Barbara CoxChief Brand & Communications Officer
- Ms. Colleen HarrisGroup Executive People · born 1968
- Mr. Pascal RocheManaging Director Ramsay Sante · born 1962
- Mr. Nick CostaMD of Ramsay UK Hospitals & Acting MD Elysium · born 1966